PLoS Pathogens (Jul 2021)

Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection.

  • Ryan J Farr,
  • Christina L Rootes,
  • Louise C Rowntree,
  • Thi H O Nguyen,
  • Luca Hensen,
  • Lukasz Kedzierski,
  • Allen C Cheng,
  • Katherine Kedzierska,
  • Gough G Au,
  • Glenn A Marsh,
  • Seshadri S Vasan,
  • Chwan Hong Foo,
  • Christopher Cowled,
  • Cameron R Stewart

DOI
https://doi.org/10.1371/journal.ppat.1009759
Journal volume & issue
Vol. 17, no. 7
p. e1009759

Abstract

Read online

The host response to SARS-CoV-2 infection provide insights into both viral pathogenesis and patient management. The host-encoded microRNA (miRNA) response to SARS-CoV-2 infection, however, remains poorly defined. Here we profiled circulating miRNAs from ten COVID-19 patients sampled longitudinally and ten age and gender matched healthy donors. We observed 55 miRNAs that were altered in COVID-19 patients during early-stage disease, with the inflammatory miR-31-5p the most strongly upregulated. Supervised machine learning analysis revealed that a three-miRNA signature (miR-423-5p, miR-23a-3p and miR-195-5p) independently classified COVID-19 cases with an accuracy of 99.9%. In a ferret COVID-19 model, the three-miRNA signature again detected SARS-CoV-2 infection with 99.7% accuracy, and distinguished SARS-CoV-2 infection from influenza A (H1N1) infection and healthy controls with 95% accuracy. Distinct miRNA profiles were also observed in COVID-19 patients requiring oxygenation. This study demonstrates that SARS-CoV-2 infection induces a robust host miRNA response that could improve COVID-19 detection and patient management.